Severe asthma: what makes it so hard to manage?

Area of Science:

• Pulmonology and Respiratory Medicine
• Clinical Immunology

Background:

• Severe asthma poses significant clinical challenges, often remaining uncontrolled despite optimal standard-of-care therapies like inhaled corticosteroids and long-acting beta-agonists.
• Factors such as alternative diagnoses, patient noncompliance, and comorbidities complicate asthma management and influence patient prognosis.

Purpose of the Study:

• To highlight the complexities in managing severe asthma.
• To emphasize the need for distinct therapeutic strategies tailored to specific severe asthma phenotypes.
• To underscore the role of pathophysiology, including airway remodeling, in treatment resistance.

Main Methods:

• Review and synthesis of current understanding of severe asthma.
• Analysis of factors influencing asthma control and treatment response.
• Exploration of the concept of distinct asthma phenotypes and their underlying mechanisms.

Main Results:

• Severe asthma is characterized by distinct pathophysiological features, such as airway remodeling, which diminish the efficacy of conventional treatments.
• Multiple phenotypes exist within severe asthma, suggesting that a one-size-fits-all approach is inadequate.

Conclusions:

• Effective management of severe asthma requires addressing confounding variables and recognizing its unique pathophysiology.
• Developing targeted therapeutic approaches for distinct severe asthma phenotypes is crucial for improving disease control and long-term health.
• Further research into these phenotypes will advance the understanding and treatment of severe asthma.